| P50 | author | Roland E Kontermann | Q87862266 |
| | Klaus Pfizenmaier | Q91723231 |
| P2093 | author name string | Martin Siegemund | |
| | Oliver Seifert | |
| | Aline Plappert | |
| | Sina Fellermeier | |
| P2860 | cites work | Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry | Q38509519 |
| | Exploring the pathogenesis of renal cell carcinoma: pathway and bioinformatics analysis of dysregulated genes and proteins | Q38511517 |
| | LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma | Q39282620 |
| | Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma | Q39296588 |
| | GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis | Q39872802 |
| | Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study | Q40005099 |
| | Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance | Q42109826 |
| | Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis | Q42846581 |
| | Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients | Q42937345 |
| | Warburg phenotype in renal cell carcinoma: high expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor | Q44320068 |
| | Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up | Q46234210 |
| | Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. | Q51806979 |
| | CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases. | Q54331256 |
| | Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. | Q54339183 |
| | miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. | Q54357850 |
| | Towards improved prognostic scores predicting survival in patients with brain metastases: a pilot study of serum lactate dehydrogenase levels. | Q55394617 |
| | Cancer as a metabolic disease | Q21245061 |
| | Renal tumors: diagnostic and prognostic biomarkers | Q26860500 |
| | Cancer statistics, 2012 | Q27860574 |
| | Glycolysis inhibition for anticancer treatment | Q28256222 |
| | Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression | Q28272474 |
| | Why do cancers have high aerobic glycolysis? | Q28290710 |
| | Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance | Q29620462 |
| | Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study | Q33510317 |
| | UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer | Q33682182 |
| | Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. | Q33880227 |
| | External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study | Q34086969 |
| | Multilevel whole-genome analysis reveals candidate biomarkers in clear cell renal cell carcinoma | Q34296301 |
| | Searching for the hereditary causes of renal-cell carcinoma | Q34318015 |
| | Metabolic imaging: a link between lactate dehydrogenase A, lactate, and tumor phenotype | Q34440549 |
| | Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma | Q34533170 |
| | Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. | Q34554861 |
| | Prognostic significance of morphologic parameters in renal cell carcinoma. | Q34716073 |
| | Molecular pathways: Fumarate hydratase-deficient kidney cancer--targeting the Warburg effect in cancer | Q35659640 |
| | Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile | Q36477174 |
| | HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation | Q36907933 |
| | LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer | Q37165231 |
| | MicroRNAs in clinical oncology: at the crossroads between promises and problems | Q37592919 |
| | Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy | Q37723006 |
| | Alterations in VHL as potential biomarkers in renal-cell carcinoma | Q37724576 |
| | Cancers with increasing incidence trends in the United States: 1999 through 2008. | Q37979107 |
| | Interactions between epigenetics and metabolism in cancers | Q38060735 |
| | Genomic medicine: new frontiers and new challenges | Q38071277 |
| | Energy management - a critical role in cancer induction? | Q38111505 |
| | Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma | Q38484441 |
| P433 | issue | 1 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 101-111 | |
| P577 | publication date | 2013-10-03 | |
| P1433 | published in | Molecular Cancer Therapeutics | Q2363144 |
| P1476 | title | Tetravalent antibody-scTRAIL fusion proteins with improved properties | |
| P478 | volume | 13 | |